• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性包涵体肌炎的新兴治疗选择

Emerging therapeutic options for sporadic inclusion body myositis.

作者信息

Alfano Lindsay N, Lowes Linda P

机构信息

Nationwide Children's Hospital, Center for Gene Therapy, Columbus, OH, USA.

出版信息

Ther Clin Risk Manag. 2015 Sep 25;11:1459-67. doi: 10.2147/TCRM.S65368. eCollection 2015.

DOI:10.2147/TCRM.S65368
PMID:26445546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4590682/
Abstract

Sporadic inclusion body myositis is the most common inflammatory muscle disorder preferentially affecting males over the age of 40 years. Progressive muscle weakness of the finger flexors and quadriceps muscles results in loss of independence with activities of daily living and eventual wheelchair dependence. Initial signs of disease are often overlooked and can lead to mis- or delayed diagnosis. The underlying cause of disease is unknown, and disease progression appears refractory to available treatment options. This review discusses the clinical presentation of inclusion body myositis and the current efforts in diagnosis, and focuses on the current state of research for both nonpharmacological and pharmacological treatment options for this patient group.

摘要

散发性包涵体肌炎是最常见的炎性肌肉疾病,好发于40岁以上男性。手指屈肌和股四头肌进行性肌无力导致日常生活活动能力丧失,最终依赖轮椅。疾病的初始症状常被忽视,可导致误诊或诊断延迟。疾病的根本原因尚不清楚,而且疾病进展似乎对现有的治疗方法无效。本文综述了包涵体肌炎的临床表现及目前的诊断方法,并重点介绍了针对该患者群体的非药物和药物治疗方案的研究现状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/707e/4590682/f485e5f508c0/tcrm-11-1459Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/707e/4590682/f485e5f508c0/tcrm-11-1459Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/707e/4590682/f485e5f508c0/tcrm-11-1459Fig1.jpg

相似文献

1
Emerging therapeutic options for sporadic inclusion body myositis.散发性包涵体肌炎的新兴治疗选择
Ther Clin Risk Manag. 2015 Sep 25;11:1459-67. doi: 10.2147/TCRM.S65368. eCollection 2015.
2
Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.包涵体肌炎与结节病性肌病:偶发还是相关疾病?
Neuromuscul Disord. 2015 Apr;25(4):297-300. doi: 10.1016/j.nmd.2014.12.005. Epub 2014 Dec 19.
3
Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.散发性包涵体肌炎在发病三年后表现为单纯性手指屈肌无力
Intern Med. 2016;55(23):3521-3524. doi: 10.2169/internalmedicine.55.7285. Epub 2016 Dec 1.
4
Inclusion body myositis: from genetics to clinical trials.包涵体肌炎:从遗传学研究到临床试验。
J Neurol. 2023 Mar;270(3):1787-1797. doi: 10.1007/s00415-022-11459-3. Epub 2022 Nov 18.
5
Sporadic inclusion body myositis presenting with severe camptocormia.散发性包涵体肌炎伴严重屈肌痉挛。
J Clin Neurosci. 2013 Nov;20(11):1628-9. doi: 10.1016/j.jocn.2013.06.004. Epub 2013 Sep 19.
6
Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.在肉芽肿性肌炎中,远隔肌肉的累及可类似包涵体肌炎。
J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):674-7. doi: 10.1136/jnnp.2009.190751. Epub 2010 Jun 20.
7
A Rare Case of Sporadic Inclusion Body Myositis (s-IBM).一例散发性包涵体肌炎(s-IBM)罕见病例。
J Clin Diagn Res. 2016 Jan;10(1):OD07-8. doi: 10.7860/JCDR/2016/14902.7111. Epub 2016 Jan 1.
8
Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.卵泡抑素基因疗法治疗散发性包涵体肌炎可改善功能预后。
Mol Ther. 2017 Apr 5;25(4):870-879. doi: 10.1016/j.ymthe.2017.02.015. Epub 2017 Mar 6.
9
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.散发性包涵体肌炎 12 年随访:终末期伴严重残疾。
Brain. 2011 Nov;134(Pt 11):3167-75. doi: 10.1093/brain/awr217. Epub 2011 Sep 9.
10
A novel case of inclusion body myositis and myasthenia gravis.一例包涵体肌炎和重症肌无力的新病例。
Neuromuscul Disord. 2019 Oct;29(10):771-775. doi: 10.1016/j.nmd.2019.09.004. Epub 2019 Sep 6.

引用本文的文献

1
Whole-body-electro-myostimulation for the care of inclusion body myositis-A case report.全身肌电刺激用于治疗包涵体肌炎——病例报告
Clin Case Rep. 2024 Oct 30;12(11):e9539. doi: 10.1002/ccr3.9539. eCollection 2024 Nov.
2
A cross-sectional study of hand function in inclusion body myositis: Implications for functional rating scale.包涵体肌炎手部功能的横断面研究:对功能评定量表的影响。
Neuromuscul Disord. 2020 Mar;30(3):200-206. doi: 10.1016/j.nmd.2019.12.002. Epub 2019 Dec 17.
3
Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

本文引用的文献

1
Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.胞质5'-核苷酸酶1A作为自身免疫性疾病中循环自身抗体的靶点
Arthritis Care Res (Hoboken). 2016 Jan;68(1):66-71. doi: 10.1002/acr.22600.
2
Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis.散发性包涵体肌炎的磁共振成像模式识别
Muscle Nerve. 2015 Dec;52(6):956-62. doi: 10.1002/mus.24661. Epub 2015 Aug 31.
3
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
日本散发性包涵体肌炎的多中心问卷调查
Orphanet J Rare Dis. 2016 Nov 8;11(1):146. doi: 10.1186/s13023-016-0524-x.
散发性包涵体肌炎中抗胞质5'-核苷酸酶1A自身抗体相对于已知自身免疫性疾病的疾病特异性
Ann Rheum Dis. 2016 Apr;75(4):696-701. doi: 10.1136/annrheumdis-2014-206691. Epub 2015 Feb 24.
4
Discovery of new biomarkers of idiopathic inflammatory myopathy.特发性炎性肌病新生物标志物的发现
Clin Chim Acta. 2015 Apr 15;444:117-25. doi: 10.1016/j.cca.2015.02.007. Epub 2015 Feb 11.
5
The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.TOMM40基因内含子多态性及APOE基因型在散发性包涵体肌炎中的作用。
Neurobiol Aging. 2015 Apr;36(4):1766.e1-1766.e3. doi: 10.1016/j.neurobiolaging.2014.12.039. Epub 2015 Jan 14.
6
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.散发性包涵体肌炎中的淀粉样沉积和炎性浸润:炎性之卵先于退行性之鸡出现。
Acta Neuropathol. 2015 May;129(5):611-24. doi: 10.1007/s00401-015-1384-5. Epub 2015 Jan 13.
7
205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands.第205届ENMC国际研讨会:特发性炎性肌病的病理学诊断 第二部分 2014年3月28日至30日,荷兰纳尔登
Neuromuscul Disord. 2015 Mar;25(3):268-72. doi: 10.1016/j.nmd.2014.12.001. Epub 2014 Dec 10.
8
Demographic and clinical features of inclusion body myositis in North America.北美包涵体肌炎的人口统计学和临床特征。
Muscle Nerve. 2015 Oct;52(4):527-33. doi: 10.1002/mus.24562. Epub 2015 Feb 17.
9
Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches.包涵体肌炎:临床与遗传学方面、诊断标准及治疗方法综述
J Clin Neurosci. 2015 Jan;22(1):6-13. doi: 10.1016/j.jocn.2014.09.012. Epub 2014 Dec 12.
10
Treatment of sporadic inclusion body myositis with bimagrumab.采用比马鲁单抗治疗散发性包涵体肌炎。
Neurology. 2014 Dec 9;83(24):2239-46. doi: 10.1212/WNL.0000000000001070. Epub 2014 Nov 7.